chr4-186162869-T-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001395294.1(FAM149A):āc.1627T>Gā(p.Tyr543Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00119 in 1,567,670 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y543C) has been classified as Uncertain significance.
Frequency
Consequence
NM_001395294.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FAM149A | NM_001395294.1 | c.1627T>G | p.Tyr543Asp | missense_variant | 9/14 | ENST00000706927.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FAM149A | ENST00000706927.1 | c.1627T>G | p.Tyr543Asp | missense_variant | 9/14 | NM_001395294.1 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000776 AC: 117AN: 150868Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000739 AC: 184AN: 249002Hom.: 1 AF XY: 0.000743 AC XY: 100AN XY: 134572
GnomAD4 exome AF: 0.00124 AC: 1752AN: 1416684Hom.: 3 Cov.: 28 AF XY: 0.00116 AC XY: 823AN XY: 706832
GnomAD4 genome AF: 0.000775 AC: 117AN: 150986Hom.: 0 Cov.: 31 AF XY: 0.000705 AC XY: 52AN XY: 73730
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 22, 2023 | The c.754T>G (p.Y252D) alteration is located in exon 9 (coding exon 6) of the FAM149A gene. This alteration results from a T to G substitution at nucleotide position 754, causing the tyrosine (Y) at amino acid position 252 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at